Fatal Idiopathic Hyperammonemia after Induction Chemotherapy for Acute Myeloid Leukemia
Idiopathic hyperammonemia is a rare but potentially fatal complication occurring in patients with acute leukemia or bone marrow transplantation. The role of some specific anticancer drugs may be discussed, but the etiology of hyperammonemia is often multifactorial. We report the case of a 40-year-ol...
Main Authors: | Christophe Angelo, Marie-Françoise Vincent, Mina Komuta, Philippe Hantson, Nicole Straetmans, Edwige Boulet |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/3136074 |
Similar Items
-
Idiopathic hyperammonemia after chemotherapy with vinorelbine, topotecan, and cisplatin in a patient with acute lymphocytic leukemia
by: Yu-Hsien Chen, et al.
Published: (2010-10-01) -
Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy
by: Thomas Büchner, et al.
Published: (2004-03-01) -
Acute Myeloid Leukemia (AML): The Role of Intensive Induction Chemotherapy
by: Thomas Büchner, et al.
Published: (2004-07-01) -
Papular eruption after induction chemotherapy for acute myeloid leukemia
by: Taylor Novice, BS, et al.
Published: (2020-02-01) -
Infectious complications during induction chemotherapy in children with acute myeloid leukemia
by: K.G. Gopakumar, et al.
Published: (2016-01-01)